{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:08:12Z","timestamp":1746331692462,"version":"3.40.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Similarities between luteinized thecoma associated with sclerosing peritonitis (LTSP) and thecoma, cause difficulty in clinical differential diagnoses. To improve the situation, we selected 10 specified molecular pathological markers that are frequently used in clinical pathology of ovarian sex cord-stromal tumors to determine whether they exert a discriminatory effect.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Applying immunohistochemistry, we analyzed the expression of alpha-1,6-mannosylglycoprotein 6-beta-<jats:sc>n<\/jats:sc>-acetylglucosaminyltransferase B (MGAT5B), nuclear receptor coactivator 3 (NCOA3), proliferation marker protein Ki-67 (MKI67), estrogen receptor, progesterone receptor, Vimentin, receptor tyrosine-protein kinase erbB-2, Catenin beta-1 (\u03b2-Catenin), CD99 antigen (CD99) and Wilms tumor protein (WT1) in 102 cases of diseases containing 11 LTSP and 91 thecoma. Whole-exome sequencing and fluorescence in situ hybridization were used to examine the MGAT5B-NCOA3 fusion gene in LTSP. Statistical analysis was performed using <jats:italic toggle=\"yes\">t<\/jats:italic> test, one-way analysis of variance test, and post hoc test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Six significant markers were verified for the discrimination between LTSP and thecoma, containing 4 upregulating indicators MGAT5B, NCOA3, MKI67, \u03b2-Catenin, and 2 downregulating markers CD99 and WT1 in luteinized cells. In addition, the MGAT5B-NCOA3 fusion gene was identified in LTSP for the first time with significantly rich expression compared to thecoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>We verified 6 significant molecular pathological markers containing MGAT5B, NCOA3, MKI67, \u03b2-Catenin, CD99, and WT1 and identified MGAT5B-NCOA3 fusion gene in LTSP; this work will help clinicians to discriminate between medical conditions and treat patients accurately.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000033911","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T14:17:08Z","timestamp":1686320228000},"page":"e33911","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Pathological discrimination between luteinized thecoma associated with sclerosing peritonitis and thecoma"],"prefix":"10.1097","volume":"102","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Obstetrics & Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Hubei Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Hubei Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Hubei Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juncheng","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Hubei Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ajog.2008.03.053","article-title":"Incidence, clinical analysis, and management of ovarian fibromas and fibrothecomas.","volume":"199","author":"Chechia","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14737140.2021.1837629","article-title":"Luteinized thecoma (thecomatosis) with sclerosing peritonitis: a systematic review of the literature of the last 25 years.","volume":"21","author":"Muratori","year":"2021","journal-title":"Expert Rev Anticancer Ther"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.prp.2010.07.001","article-title":"Mitotically active cellular luteinized thecoma of the ovary and luteinized thecomatosis associated with sclerosing peritonitis: case studies, comparison, and review of the literature.","volume":"206","author":"Mellembakken","year":"2010","journal-title":"Pathol Res Pract"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14737140.2021.1853530","article-title":"Luteinized thecomatosis and other conditions associated with sclerosing peritonitis: a problem in causation, management, and nomenclature.","volume":"21","author":"Roth","year":"2021","journal-title":"Expert Rev Anticancer Ther"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/his.14609","article-title":"Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020).","volume":"80","author":"McCluggage","year":"2022","journal-title":"Histopathology"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1445-2197.1993.tb00391.x","article-title":"Diffuse intra-abdominal fibromatosis in association with bilateral ovarian fibromatosis and oedema.","volume":"63","author":"Antoniuk","year":"1993","journal-title":"Aust N Z J Surg"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ygyno.2004.10.044","article-title":"Ovarian luteinized thecoma with sclerosing peritonitis in an adult woman treated with leuprolide and toremifene in complete remission at 5 years.","volume":"96","author":"Bianco","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1440-1827.1996.tb03646.x","article-title":"Sclerosing peritonitis associated with luteinized thecoma of the ovary.","volume":"46","author":"Iwasa","year":"1996","journal-title":"Pathol Int"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00004347-198203000-00004","article-title":"Ovarian stromal tumors containing lutein or Leydig cells (luteinized thecomas and stromal Leydig cell tumors) \u2013 a clinicopathological analysis of fifty cases.","volume":"1","author":"Zhang","year":"1982","journal-title":"Int J Gynecol Pathol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/PAS.0b013e3181666a5f","article-title":"Luteinized thecomas (Thecomatosis) of the type typically associated with sclerosing peritonitis: a clinical, histopathologic, and immunohistochemical analysis of 27 cases.","volume":"32","author":"Staats","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-199401000-00001","article-title":"Sclerosing peritonitis associated with luteinized thecomas of the ovary. a clinicopathological analysis of six cases.","volume":"18","author":"Clement","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.gore.2019.02.004","article-title":"Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment.","volume":"28","author":"Muratori","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"R13-20250504","first-page":"33","article-title":"17\u03b2\u2011estradiol\u2011induced mitochondrial dysfunction and Warburg effect in cervical cancer cells allow cell survival under metabolic stress.","volume":"56","author":"Riera Leal","year":"2020","journal-title":"Int J Oncol"},{"key":"R14-20250504","first-page":"585","article-title":"Decreased miR-124-3p promoted breast cancer proliferation and metastasis by targeting MGAT5.","volume":"9","author":"Yan","year":"2019","journal-title":"Am J Cancer Res"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1158\/1535-7163.MCT-08-1028","article-title":"Estrogen-related receptor-\u03b1 antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts.","volume":"8","author":"Chisamore","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1186\/1471-2407-13-570","article-title":"NCOA3 is a selective co-activator of estrogen receptor \u03b1-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.","volume":"13","author":"Wagner","year":"2013","journal-title":"BMC Cancer"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12020-021-02819-6","article-title":"NCOA3 is a critical oncogene in thyroid cancer via the modulation of major signaling pathways.","volume":"75","author":"Li","year":"2022","journal-title":"Endocrine"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"28612861","DOI":"10.3390\/cells10112861","article-title":"A-kinase anchoring protein 2 promotes protection against myocardial infarction.","volume":"10","author":"Maric","year":"2021","journal-title":"Cells"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"52412","DOI":"10.1074\/jbc.M308837200","article-title":"N-acetylglucosaminyltransferase V expression levels regulate cadherin-associated homotypic cell-cell adhesion and intracellular signaling pathways.","volume":"278","author":"Guo","year":"2003","journal-title":"J Biol Chem"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41419-020-03218-x","article-title":"Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma.","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1878-0261.12173","article-title":"MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation.","volume":"12","author":"Li","year":"2018","journal-title":"Mol Oncol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1038\/srep02529","article-title":"Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma.","volume":"3","author":"Qiu","year":"2013","journal-title":"Sci Rep"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.pas.0000157938.95785.da","article-title":"Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions.","volume":"29","author":"Bhattacharya","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.exphem.2008.10.007","article-title":"beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.","volume":"37","author":"Nygren","year":"2009","journal-title":"Exp Hematol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb1684","article-title":"TBL1-TBLR1 and beta-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis.","volume":"10","author":"Li","year":"2008","journal-title":"Nat Cell Biol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.molcel.2015.01.025","article-title":"Structure of a biologically active estrogen receptor-coactivator complex on DNA.","volume":"57","author":"Yi","year":"2015","journal-title":"Mol Cell"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.toxrep.2019.10.016","article-title":"Evaluation of tamoxifen and simvastatin as the combination therapy for the treatment of hormonal dependent breast cancer cells.","volume":"6","author":"Ibrahim","year":"2019","journal-title":"Toxicol Rep"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00262-020-02789-0","article-title":"Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma.","volume":"70","author":"Takheaw","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbrc.2022.03.087","article-title":"Role of CD99 in regulating homeostasis and differentiation in normal human epidermal keratinocytes.","volume":"606","author":"Wong","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"jcs240135","DOI":"10.1242\/jcs.240135","article-title":"Tumour cell CD99 regulates transendothelial migration via CDC42 and actin remodelling.","volume":"134","author":"Mannion","year":"2021","journal-title":"J Cell Sci"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3324\/haematol.2021.279601","article-title":"Tumor suppressor function of WT1 in acute promyelocytic leukemia.","volume":"107","author":"Christopher","year":"2022","journal-title":"Haematologica"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.stemcr.2021.07.023","article-title":"The tumor suppressor WT1 drives progenitor cell progression and epithelialization to prevent Wilms tumorigenesis in human kidney organoids.","volume":"16","author":"Waehle","year":"2021","journal-title":"Stem Cell Rep"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.humpath.2004.11.011","article-title":"The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.","volume":"36","author":"Cathro","year":"2005","journal-title":"Hum Pathol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0046-8177(98)90454-3","article-title":"M\u00fcllerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors.","volume":"29","author":"Matias-Guiu","year":"1998","journal-title":"Hum Pathol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"563","DOI":"10.5858\/2000-124-0563-IOISIA","article-title":"Immunoexpression of inhibin alpha subunit, inhibin\/activin betaA subunit and CD99 in ovarian tumors.","volume":"124","author":"Choi","year":"2000","journal-title":"Arch Pathol Lab Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:05:53Z","timestamp":1746324353000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":35,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033911","relation":{},"ISSN":["0025-7974"],"issn-type":[{"type":"print","value":"0025-7974"}],"subject":[],"published":{"date-parts":[[2023,6,9]]}}}